Acute respiratory distress syndrome patients improve with experimental monoclonal antibody treatment
Doctors have few options for patients who develop a life-threatening lung condition called acute respiratory distress syndrome, or ARDS. A frequent cause of death during the COVID-19 pandemic, ARDS ...
Vatche and Tamar Manoukian Division of Digestive Diseases, G. Oppenheimer Center for Neurobiology of Stress and Resilience, Clinical Studies and Database Core, Goodman-Luskin Microbiome Center, David ...
The “2023 Guideline for the Management of Patients With Aneurysmal Subarachnoid Hemorrhage” replaces the 2012 “Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage.” The 2023 guideline ...
aCLEAR Methods Center, Division of Clinical Epidemiology, University Hospital Basel, Basel, Switzerland bDepartment of Clinical Research, University Hospital Basel, Basel, Switzerland oDépartement des ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results